The Japanese research firm has maintained its reduce rating on the stock with a target of Rs 570, a downside of 29 percent Read More Top 100 Best Sellers Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment. Δ previousTitan#39;s eye care brand seeks partners to achieve greater #39;technological edge#39;: ReportnextMeta to delay closing Within Unlimited deal by one month